Case Study
Fast and Flexible – Early Phase Manufacturing
Early-stage manufacturers of oral solid dosage forms need to be fast and flexible to generate development pathways that can cope with variable API characteristics as well as highly potent molecules. Technology, risk assessment, Quality by Design and scale up are all in the mix of considerations.
First Published by European Biopharmaceutical Review
